Skip to content
Dx

ICD-10-CM 2027 diagnosis code

H02.882Meibomian gland dysfunction right lower eyelid

✓ Billable / specific

H02.882 is a valid, billable ICD-10-CM code for meibomian gland dysfunction right lower eyelid. It can be reported on claims for dates of service from October 1, 2026 – September 30, 2027.

Code last changed in FY2019 (effective October 1, 2018). Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data

About H02.882

H02.882 is the ICD-10-CM diagnosis code for Meibomian gland dysfunction right lower eyelid. It belongs to category H02 (other disorders of eyelid), block H00-H05 (disorders of eyelid, lacrimal system and orbit) and chapter 7 (diseases of the eye and adnexa). It is billable, so it can be reported on its own for dates of service from October 1, 2026 through September 30, 2027.

Within H02.88 (Meibomian gland dysfunction of eyelid), H02.882 is specifically for Meibomian gland dysfunction right lower eyelid. Related codes cover right upper eyelid (H02.881), of right eye, unspecified eyelid (H02.883), left upper eyelid (H02.884), left lower eyelid (H02.885), of left eye, unspecified eyelid (H02.886), of unspecified eye, unspecified eyelid (H02.889), right eye, upper and lower eyelids (H02.88A) and left eye, upper and lower eyelids (H02.88B).

It is not a CC or MCC, so as a secondary diagnosis it doesn't change the MS-DRG severity level.

In MS-DRG v44.0, it is part of the grouping logic for DRG 124 (Other Disorders of the Eye with MCC or Thrombolytic Agent, relative weight 1.2471) and DRG 125 (Other Disorders of the Eye without MCC, relative weight 0.7702), in MDC 02 (Diseases and Disorders of the Eye), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.

It was added in FY2019, effective October 1, 2018.

Notes that apply from higher levels

Instructions written at a parent level also apply to H02.882.

› From H02 Other disorders of eyelid
Excludes1

Broader instructions also apply from H00-H05 Disorders of eyelid, lacrimal system and orbit and Chapter 7: Diseases of the eye and adnexa.

Alphabetic index entries

1 entries

Terms in the official ICD-10-CM index that lead to H02.882.

MS-DRG v44.0 grouping

All DRGs →

Inpatient MS-DRGs this diagnosis can group to, as the principal or a secondary diagnosis, depending on the rest of the claim.

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2019 (effective 10/1/2018): Added
  • No changes since FY2019.

Common questions about H02.882

Is H02.882 billable?

Yes. H02.882 is a billable/specific ICD-10-CM code valid for FY2027 (October 1, 2026 – September 30, 2027).

Can H02.882 be used as a principal diagnosis?

Yes. The Medicare Code Editor doesn't restrict H02.882 as a principal diagnosis.

Is H02.882 a CC or MCC?

No. H02.882 is neither a CC nor an MCC under MS-DRG v44.0.

What DRG does H02.882 group to?

H02.882 is used in the MS-DRG v44.0 logic for MS-DRG 124 (Other Disorders of the Eye with MCC or Thrombolytic Agent) and MS-DRG 125 (Other Disorders of the Eye without MCC). Which one applies depends on whether it is the principal diagnosis and on the rest of the claim.